Search

Bio Roundup: Drug Prices, CRISPR Caveats, Rubius IPO Pop & More

BIO ROUNDUP: DRUG PRICES, CRISPR CAVEATS, RUBIUS IPO POP & MORE

After nearly two years of all smoke, no fire around President Trump's promise to curtail drug prices, there's finally some glimmer...

Fresh Off Bristol Buyout, IFM Backers Raise $31M to Plot a Second Strike

FRESH OFF BRISTOL BUYOUT, IFM BACKERS RAISE $31M TO PLOT A SECOND STRIKE

Nearly one year ago, biotech startup IFM Therapeutics sold some of its assets to Bristol-Myers Squibb for $300 million. But IFM's founders...

 
 
 

PEGYLATED SELF-ASSEMBLED ENZYME-RESPONSIVE NANOPARTICLES FOR EFFECTIVE TARGETED THERAPY AGAINST LUNG TUMORS

Matrix-metalloproteinases, which are overexpressed in many types of cancer, can be applied to improve the bioavailability of chemotherapeutic...

 
 
 

MIRATI THERAPEUTICS: DIRECTOR/SR. DIRECTOR, MEDICINAL CHEMISTRY

Mirati Therapeutics: SUMMARY: The Drug Discovery team at Mirati is responsible for the invention, optimization and characterization...

PLIANT PICKS UP $62M TO TEST LUNG, LIVER FIBROSIS DRUG IN THE CLINIC

The cause of fibrosis, the hardening and thickening of connective tissue in organs, isn't known and it has few treatments. Pliant Therapeutics...

 
 
 
New Study Shows CRISPR Can Delete Big Chunks of DNA

NEW STUDY SHOWS CRISPR CAN DELETE BIG CHUNKS OF DNA

[ Updated 7/16/18 1:00pm ET, see note below ] As CRISPR-based therapeutics inch closer to human tests in the U.S., academic researchers...

PLIANT THERAPEUTICS CLOSES $62M ROUND, EYEING FIBROTIC DISEASE WORK

California startup Pliant Therapeutics has raised a healthy $62 million series B to help fund its proof of concept tests across a range...

 
 
 
The top 5 startups disrupting healthcare within AI, digital therapeutics, health insurance, and genomics

THE TOP 5 STARTUPS DISRUPTING HEALTHCARE WITHIN AI, DIGITAL THERAPEUTICS, HEALTH INSURANCE, AND GENOMICS

Business Insider Intelligence The healthcare industry is facing disruption due to accelerating technological innovation and growing...

EU Regulators Approve Akcea's Inotersen. FDA Decisions Are Next

EU REGULATORS APPROVE AKCEA'S INOTERSEN. FDA DECISIONS ARE NEXT

Akcea Therapeutics has beaten rival Alnylam Pharmaceuticals to a first drug approval, getting the nod for its drug inotersen in the...

 
 
 
Tango, Finch, Indigo & More: The 2018 Xconomy Award Startup Finalists

TANGO, FINCH, INDIGO & MORE: THE 2018 XCONOMY AWARD STARTUP FINALISTS

This year's bumper crop of Xconomy Award startup finalists cover a wide range of technologies and approaches, from microbiome and gene...

THERAPEUTICS, INC.: CLINICAL RESEARCH ASSOCIATE

Therapeutics, Inc.: PRIMARY OBJECTIVE OF THE POSITION: The primary objective of the Clinical Research Associate is to monitor clinical...

 
 
 
Study shows that acupuncture can provide relief to those suffering from anxiety-related disorders

STUDY SHOWS THAT ACUPUNCTURE CAN PROVIDE RELIEF TO THOSE SUFFERING FROM ANXIETY-RELATED DISORDERS

A study published in BMC Complementary and Alternative Medicine examined the therapeutic effects of acupuncture on behavioral changes...

HALOZYME TO HOST SECOND QUARTER 2018 FINANCIAL RESULTS CONFERENCE CALL

SAN DIEGO, July 6, 2018 /PRNewswire/ - Halozyme Therapeutics, Inc. , a biotechnology company developing novel oncology and drug-delivery...

 
 
 

REGULUS ANNOUNCES STRATEGIC UPDATE AND CORPORATE RESTRUCTURING

Efforts Aimed at Extending Cash Runway to mid-2019 LA JOLLA, Calif., July 5, 2018 /PRNewswire/ - Regulus Therapeutics Inc. , a biopharmaceutical...

 
 
 
Researchers look at the potential of Rhazya stricta Decne in preventing neurodegenerative diseases

RESEARCHERS LOOK AT THE POTENTIAL OF RHAZYA STRICTA DECNE IN PREVENTING NEURODEGENERATIVE DISEASES

Research has shown that Rhazya stricta Decne, a medicinal plant native to the Arabian Peninsula, could potentially be used as a therapeutic...

The therapeutic heart benefits of long-term administration of Nigella sativa

THE THERAPEUTIC HEART BENEFITS OF LONG-TERM ADMINISTRATION OF NIGELLA SATIVA

Fennel or Nigella sativa has been shown to offer plenty of benefits for the heart. A study published in BMC Complementary and Alternative...

 
 
 
The Art of Perseverance: Meet Xconomy's Six CEO Award Finalists

THE ART OF PERSEVERANCE: MEET XCONOMY'S SIX CEO AWARD FINALISTS

The Xconomy Awards are back, and today we're kicking things off by taking a look at our first set of finalists -the top Boston biotech...

New science: The therapeutic effects of long-needle acupuncture on chronic pelvic pain syndrome

NEW SCIENCE: THE THERAPEUTIC EFFECTS OF LONG-NEEDLE ACUPUNCTURE ON CHRONIC PELVIC PAIN SYNDROME

A study published in the journal BMC Complementary and Alternative Medicine has found that deep needling at acupoints BL30 and BL36...